19.92
-0.35 (-1.73%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Insurance - Life (US) | Mixed | Mixed |
| Insurance - Life (Global) | Mixed | Mixed | |
| Stock | Ethos Technologies Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -5.0 |
| Price Volatility | 1.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 2.0 |
| Average | -1.13 |
|
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis. |
|
| Sector | Financial Services |
| Industry | Insurance - Life |
| Investment Style | Small Value |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| GV 2019 GP, L.L.C. | - | 18.88 | -1,026,370 | -19,605,471 |
| Aggregate Net Quantity | -1,026,370 | |||
| Aggregate Net Value ($) | -19,605,471 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 18.88 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| GV 2019 GP, L.L.C. | 28 Jul 2026 | Disposed (-) | 118,138 | 18.80 | 2,220,994 | |
| GV 2019 GP, L.L.C. | 28 Jul 2026 | Sell (-) | 118,138 | 18.80 | 2,220,994 | |
| GV 2019 GP, L.L.C. | 27 Jul 2026 | Disposed (-) | 196,931 | 19.48 | 3,836,216 | |
| GV 2019 GP, L.L.C. | 27 Jul 2026 | Sell (-) | 196,931 | 19.48 | 3,836,216 | |
| GV 2019 GP, L.L.C. | 24 Jul 2026 | Disposed (-) | 23,417 | 18.50 | 433,215 | |
| GV 2019 GP, L.L.C. | 24 Jul 2026 | Sell (-) | 23,417 | 18.50 | 433,215 | |
| GV 2019 GP, L.L.C. | 23 Jul 2026 | Disposed (-) | 63,297 | 19.03 | 1,204,542 | |
| GV 2019 GP, L.L.C. | 23 Jul 2026 | Sell (-) | 63,297 | 19.03 | 1,204,542 | |
| GV 2019 GP, L.L.C. | 22 Jul 2026 | Disposed (-) | 49,582 | 19.23 | 953,462 | |
| GV 2019 GP, L.L.C. | 22 Jul 2026 | Sell (-) | 49,582 | 19.23 | 953,462 | |
| GV 2019 GP, L.L.C. | 21 Jul 2026 | Disposed (-) | 22,900 | 18.83 | 431,207 | |
| GV 2019 GP, L.L.C. | 21 Jul 2026 | Sell (-) | 22,900 | 18.83 | 431,207 | |
| GV 2019 GP, L.L.C. | 20 Jul 2026 | Disposed (-) | 18,386 | 18.50 | 340,141 | |
| GV 2019 GP, L.L.C. | 20 Jul 2026 | Sell (-) | 18,386 | 18.50 | 340,141 | |
| GV 2019 GP, L.L.C. | 17 Jul 2026 | Disposed (-) | 20,534 | 18.65 | 382,959 | |
| GV 2019 GP, L.L.C. | 17 Jul 2026 | Sell (-) | 20,534 | 18.65 | 382,959 | |
| Show more | ||||||
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |